| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 52,8 k € | +21.2% | 43,6 k € | -34.6% | 66,6 k € | +64.1% | 40,6 k € | -31.1% | 58,9 k € | +12.7% | 52,3 k € | +37.3% | 38,1 k € | +2.4% | 37,2 k € | -26.7% | 50,7 k € | +4.3% | 48,6 k € | +48.0% | 32,8 k € | +54.3% | 21,3 k € | -40.8% | 36,0 k € | -23.2% | 46,8 k € | +38.9% | 33,7 k € | |
| EBITDA | 52,1 k € | +21.4% | 42,9 k € | -34.7% | 65,8 k € | +64.2% | 40,1 k € | -31.0% | 58,0 k € | +12.8% | 51,4 k € | +37.9% | 37,3 k € | +2.4% | 36,4 k € | -27.1% | 49,9 k € | +4.4% | 47,8 k € | +49.2% | 32,1 k € | +60.3% | 20,0 k € | -43.2% | 35,2 k € | -23.4% | 46,0 k € | +39.4% | 33,0 k € | |
| Operating profit | 40,3 k € | +33.1% | 30,3 k € | -44.8% | 54,8 k € | +159.4% | 21,1 k € | -46.7% | 39,6 k € | +114.3% | 18,5 k € | +296.0% | 4,7 k € | +231.8% | 1,4 k € | -94.5% | 25,6 k € | +4.7% | 24,5 k € | +195.2% | 8,3 k € | +269.0% | -4,9 k € | -364.8% | -1,1 k € | -110.6% | 9,9 k € | +2805.1% | 341,3 € | |
| Profit/loss | 23,9 k € | +42.2% | 16,8 k € | -54.0% | 36,6 k € | +199.7% | 12,2 k € | -56.5% | 28,0 k € | +191.0% | 9,6 k € | +736.7% | -1,5 k € | +71.0% | -5,2 k € | -163.9% | 8,2 k € | +16.6% | 7,0 k € | +284.3% | -3,8 k € | +30.1% | -5,4 k € | -138.1% | -2,3 k € | -131.8% | 7,2 k € | +1296.7% | -600,6 € | |
| Equity | 148,9 k € | +19.1% | 125,0 k € | +22.1% | 102,4 k € | +55.6% | 65,8 k € | +22.8% | 53,6 k € | +109.8% | 25,5 k € | +60.6% | 15,9 k € | -8.7% | 17,4 k € | -23.1% | 22,6 k € | +56.5% | 14,5 k € | +94.1% | 7,5 k € | -33.8% | 11,3 k € | -32.6% | 16,7 k € | -12.0% | 19,0 k € | +60.9% | 11,8 k € | |
| Total assets | 196,9 k € | +11.6% | 176,3 k € | +8.1% | 163,2 k € | +16.9% | 139,6 k € | -0.5% | 140,2 k € | +12.5% | 124,6 k € | -3.5% | 129,1 k € | -18.1% | 157,6 k € | +1.2% | 155,8 k € | -11.2% | 175,5 k € | -2.3% | 179,6 k € | -17.3% | 217,1 k € | -5.3% | 229,3 k € | -3.4% | 237,3 k € | +0.7% | 235,7 k € | |
| Cash | 66,4 k € | -10.0% | 73,7 k € | -10.3% | 82,2 k € | +0.6% | 81,7 k € | +1.9% | 80,2 k € | +4.3% | 76,9 k € | +39.1% | 55,3 k € | -7.7% | 59,9 k € | -18.7% | 73,7 k € | +5.0% | 70,2 k € | +26.8% | 55,4 k € | -24.2% | 73,0 k € | -9.2% | 80,4 k € | +71.6% | 46,8 k € | +117.4% | 21,6 k € | |
| Debts | 44,4 k € | -8.4% | 48,5 k € | -17.1% | 58,5 k € | -16.6% | 70,1 k € | -14.6% | 82,1 k € | -13.7% | 95,0 k € | -12.2% | 108,2 k € | -18.3% | 132,5 k € | +5.3% | 125,8 k € | -17.9% | 153,2 k € | -6.1% | 163,2 k € | -20.7% | 205,8 k € | -3.2% | 212,6 k € | -2.6% | 218,3 k € | -2.3% | 223,4 k € | |
Private limited company profitable and well capitalised. Cash position declining (-10.0%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
OPHTALMOLOGY DOCTEUR CHRISTINE BRICHARD is a Private limited company incorporated in 2010. Its main activity is: Other human health activities. Its registered office is in Libramont-Chevigny.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette